Trial intelligence / Profile preview

Inhaled Mannitol in Adult Cystic Fibrosis

NCT02134353Phase 3Completed

Sponsor
Syntara Limited
Start
Sep 2014
Primary completion
Feb 2017
Modality
Inhalation Devices, Small Molecules
Countries
18
01

Overview

A Phase 3 trial of Bronchitol in cystic fibrosis (CF), sponsored by Syntara Limited. Started Sep 2014; status: completed.

02

Drugs

Bronchitol
03

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT02134353.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02134353.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call